UY27306A1 - Cápsulas elásticas blandas y composiciones de las mismas - Google Patents

Cápsulas elásticas blandas y composiciones de las mismas

Info

Publication number
UY27306A1
UY27306A1 UY27306A UY27306A UY27306A1 UY 27306 A1 UY27306 A1 UY 27306A1 UY 27306 A UY27306 A UY 27306A UY 27306 A UY27306 A UY 27306A UY 27306 A1 UY27306 A1 UY 27306A1
Authority
UY
Uruguay
Prior art keywords
soft elastic
compositions
same
elastic capsule
elastic capsules
Prior art date
Application number
UY27306A
Other languages
English (en)
Inventor
Sergio Petriconi
Alessandro Barbato
Martin Urch
Roberta Scuppa
Azita S-Gerhardt
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of UY27306A1 publication Critical patent/UY27306A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una cápsula elástica blanda que contiene un agente farmacéutico o una mezcla de agentes farmacéuticos. La cápsula elástica blanda se prepara a partir de una composición de relleno y una composición de revestimiento que confiere características físicas aceptables a dicha cápsula elástica blanda cuando alcanza un estado de equilibrio. Los agentes farmacéuticos de la composición de relleno también son solubles cuando la cápsula elástica blanda está en el estado de equilibrio.
UY27306A 2001-05-25 2002-05-24 Cápsulas elásticas blandas y composiciones de las mismas UY27306A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86628501A 2001-05-25 2001-05-25

Publications (1)

Publication Number Publication Date
UY27306A1 true UY27306A1 (es) 2002-12-31

Family

ID=25347294

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27306A UY27306A1 (es) 2001-05-25 2002-05-24 Cápsulas elásticas blandas y composiciones de las mismas

Country Status (8)

Country Link
EP (1) EP1395249A1 (es)
JP (1) JP2005508294A (es)
AR (1) AR034995A1 (es)
CA (1) CA2448438A1 (es)
MX (1) MXPA03010771A (es)
PE (1) PE20030098A1 (es)
UY (1) UY27306A1 (es)
WO (1) WO2002096395A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
AU2013255666A1 (en) 2012-05-03 2014-11-20 Cipla Limited Antiretroviral composition
WO2019130341A1 (en) * 2017-12-26 2019-07-04 Hetero Labs Limited Capsule compositions comprising lopinavir and ritonavir
GB201917252D0 (en) 2019-11-27 2020-01-08 Pharmaceutic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
US6232333B1 (en) * 1996-11-21 2001-05-15 Abbott Laboratories Pharmaceutical composition
CO5090830A1 (es) * 1998-07-20 2001-10-30 Abbott Lab Poliformo de un agente farmaceutico
MXPA01012478A (es) * 1999-06-04 2003-10-14 Abbott Lab Formulaciones farmaceuticas mejoradas.
US6608198B2 (en) * 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical

Also Published As

Publication number Publication date
MXPA03010771A (es) 2004-07-01
EP1395249A1 (en) 2004-03-10
WO2002096395A1 (en) 2002-12-05
CA2448438A1 (en) 2002-12-05
PE20030098A1 (es) 2003-02-12
JP2005508294A (ja) 2005-03-31
AR034995A1 (es) 2004-04-14

Similar Documents

Publication Publication Date Title
BR9814229A (pt) Composição cosmética
CO5840249A1 (es) Composiciones lubricantes personales y equipos para proveer lubricacion personal
BR9714270A (pt) Composição lìquida de limpeza de pele
PE20020968A1 (es) Preparados de insulina exentos de zinc y pobres en zinc, con estabilidad mejorada
DE602005024601D1 (de) Zweikomponenten-zahnbleichzusammensetzungen
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
AU2003304237A1 (en) Gel-stabilized nanoparticulate active agent compositions
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
WO2006003481A3 (en) Oleaginous pharmaceutical and cosmetic foam
AR002266A1 (es) Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
HUP9902454A2 (hu) Szubsztituált 1,2,3,4-tetrahidronaftalin-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
BR0111678A (pt) Composições medicinais contendo derivados de propenona
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
UY27306A1 (es) Cápsulas elásticas blandas y composiciones de las mismas
PE20040324A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
DE60318447D1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
DK1847258T4 (da) Partialglycerider som smøremiddel til farmaceutiske sammensætninger indeholdende thieno[3,2-c]pyridin-derivater
ES2136198T3 (es) Composiciones rectales que contienen odansetron en forma de su base libre.
MXPA05012655A (es) Isomeros puros d-(17a)-13 -etil-17-hidroxi -18, 19-dinorpregn- 4-eno-20-ino -3-ona-3e -y ??3z- oxima, asi como el proceso para la sintesis de la mezcla de isomeros y los isomeros puros.
RS52818B (sr) Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141126